Probing molecular mechanisms of the Hsp90 chaperone: Biophysical modeling identifies key regulators of functional dynamics

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Dixit, Anshuman ^a,d   Verkhivker, Gennady M ^b,c  

^a UNIVERSITY OF KANSAS   (United States)

^b CHAPMAN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; CHAPERONE;

ALLOSTERISM; AMINO ACID SEQUENCE; ARTICLE; BIOPHYSICS; CATALYSIS; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; MOLECULAR MODEL; PRINCIPAL COMPONENT ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MOTIF; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS; CHEMICAL STRUCTURE; HYDROGEN BOND; METABOLISM;

BIOPHYSICS; HSP90 HEAT-SHOCK PROTEINS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR CHAPERONES; MOLECULAR DYNAMICS SIMULATION; PRINCIPAL COMPONENT ANALYSIS; PROTEIN CONFORMATION;

EID: 84862098170     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037605     Document Type: Article

References (167)

1. Pearl LH, Prodromou C, (2001) Structure, function, and mechanism of the Hsp90 molecular chaperone. Adv Protein Chem 59: 157-186.
2. Richter K, Buchner J, (2001) Hsp90: chaperoning signal transduction. J Cell Physiol 188: 281-290.
3. Young JC, Moarefi I, Hartl FU, (2001) Hsp90: a specialized but essential protein-folding tool. J Cell Biol 154: 267-273.
4. Picard D, (2002) Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci 59: 1640-1648.
5. Young JC, Agashe VR, Siegers K, Hartl UF, (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5: 781-791.
6. Wayne N, Mishra P, Bolon DN, (2011) Hsp90 and client protein maturation. Methods Mol Biol 787: 33-44.
7. Zhao R, Davey M, Hsu YC, Kaplanek P, Tong A, et al. (2005) Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 120: 715-727.
8. McClellan AJ, Xia Y, Deutschbauer AM, Davis RW, Gerstein M, et al. (2007) Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell 131: 121-135.
9. Zhao R, Houry WA, (2007) Molecular interaction network of the Hsp90 chaperone system. Adv Exp Med Biol 594: 27-36.
10. Taipale M, Jarosz DF, Lindquist S, (2010) Hsp90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515-28.
11. Hawle P, Siepmann M, Harst A, Siderius M, Reusch HP, et al. (2006) The middle domain of Hsp90 acts as a discriminator between different types of client proteins. Mol Cell Biol 26: 8358-8395.
12. Roe MS, Ali M, Meyer P, Vaughan CK, Panaretou B, et al. (2004) The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 116: 87-98.
13. Pearl LH, (2005) Hsp90 and Cdc37: a chaperone cancer conspiracy. Curr Opin Genet Dev 15: 55-61.
14. Meyer P, Prodromou C, Liao C, Hu B, Roe MS, et al. (2004) Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery. EMBO J 23: 511-519.
15. Siligardi G, Hu B, Panaretou B, Piper PW, Pearl LH, et al. (2004) Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle. J Biol Chem 279: 51989-51998.
16. Richter K, Walter S, Buchner J, (2004) The Co-chaperone Sba1 connects the ATPase reaction of Hsp90 to the progression of the chaperone cycle. J Mol Biol 342: 1403-1413.
17. Mclaughlin SH, Sobott F, Yao ZP, Zhang W, Nielsen PR, et al. (2006) The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J Mol Biol 356: 746-758.
18. Onuoha SC, Coulstock ET, Grossmann JG, Jackson SE, (2008) Structural studies on the co-chaperone Hop and its complexes with Hsp90. J Mol Biol 379: 732-744.
19. Johnson JL, Halas A, Flom G, (2007) Nucleotide-dependent interaction of Saccharomyces cerevisiae Hsp90 with the cochaperone proteins Sti1, Cpr6, and Sba1. Mol Cell Biol 27: 768-776.
20. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
21. Isaacs JS, Xu W, Neckers L, (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3: 213-217.
22. Bagatell R, Whitesell L, (2004) Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther 3: 1021-1030.
23. Whitesell L, Lindquist SL, (2005) Hsp90 and the chaperoning of cancer. Nat Rev Cancer 5: 761-772.
24. Xu W, Neckers L, (2007) Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clin Cancer Res 13: 1625-1629.
25. Neckers L, (2007) Heat shock protein 90: the cancer chaperone. J Biosci 32: 517-530.
26. Darby JF, Workman P, (2011) Chemical biology: Many faces of a cancer-supporting protein. Nature 478: 334-335.
27. Workman P, (2003) Overview: translating Hsp90 biology into Hsp90 drugs. Curr Cancer Drug Targets 3: 297-300.
28. Mcdonald E, Workman P, Jones K, (2006) Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer. Curr Top Med Chem 6: 1091-1107.
29. Sharp S, Workman P, (2006) Inhibitors of the HSP90 molecular chaperone: current status. Adv Cancer Res 95: 323-348.
30. Workman P, de Billy E, (2007) Putting the heat on cancer. Nat Med 13: 1415-1417.
31. Workman P, Burrows F, Neckers L, Rosen N, (2007) Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 1113: 202-216.
32. van Montfort RL, Workman P, (2009) Structure-based design of molecular cancer therapeutics. Trends Biotechnol 27: 315-328.
33. Gao Z, Garcia-Echeverria C, Jensen MR, (2010) Hsp90 inhibitors: clinical development and future opportunities in oncology therapy. Curr Opin Drug Discov Devel 13: 193-202.
34. Beck R, Dejeans N, Glorieux C, Pedrosa RC, Vásquez D, et al. (2011) Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies. Curr Med Chem 18: 2816-2825.
35. Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, et al. (2011) Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol 7: 818-826.
36. Obermann WM, Sondermann H, Russo AA, Pavletich NP, Hartl FU, (1998) In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J Cell Biol 143: 901-910.
37. Panaretou B, Prodromou C, Roe SM, O'Brien R, Ladbury JE, et al. (1998) ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J 17: 4829-4836.
38. Prodromou C, Panaretou B, Chohan S, Siligardi G, O'Brien R, et al. (2000) The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains. EMBO J 19: 4383-4392.
39. Chadli A, Bouhouche I, Sullivan W, Stensgard B, Mcmahon N, et al. (2000) Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90. Proc Natl Acad Sci U S A 97: 12524-12529.
40. Meyer P, Prodromou C, Hu B, Vaughan C, Roe MS, et al. (2003) Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions. Mol Cell 11: 647-658.
41. Pearl LH, Prodromou C, (2006) Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 75: 271-294.
42. Pearl LH, Prodromou C, Workman P, (2008) The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J 410: 439-453.
43. Eleuteri AM, Cuccioloni M, Bellesi J, Lupidi G, Fioretti E, et al. (2002) Interaction of Hsp90 with 20S proteasome: thermodynamic and kinetic characterization. Proteins 48: 169-177.
44. Mayer MP, (2010) Gymnastics of molecular chaperones. Mol Cell 39: 321-331.
45. Krukenberg KA, Street TO, Lavery LA, Agard DA, (2011) Conformational dynamics of the molecular chaperone Hsp90. Q Rev Biophys 2011 44: 229-255.
46. Li J, Soroka J, Buchner J, (2012) The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones. Biochim Biophys Acta 1823: 624-635.
47. Prodromou C, Roe SM, Piper PW, Pearl LH, (1997) A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone. Nat Struct Biol 4: 477-482.
48. Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, et al. (1997) Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90: 65-75.
49. Huai Q, Wang H, Liu Y, Kim HY, Toft D, et al. (2005) Structures of the N-terminal and middle domains of E. coli Hsp90 and conformation changes upon ADP binding. Structure 13: 579-590.
50. Hawle P, Siepmann M, Harst A, Siderius M, Reusch HP, et al. (2006) The middle domain of Hsp90 acts as a discriminator between different types of client proteins. Mol Cell Biol 26: 8385-8395.
51. Immormino RM, Dollins DE, Shaffer PL, Soldano KL, Walker MA, et al. (2004) Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone. J Biol Chem 279: 46162-46171.
52. Dollins DE, Immormino RM, Gewirth DT, (2005) Structure of unliganded GRP94, the endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational change. J Biol Chem 280: 30438-30447.
53. Harris SF, Shiau AK, Agard DA, (2004) The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site. Structure 12: 1087-1097.
54. Ali MM, Roe SM, Vaughan CK, Meyer P, Panaretou B, et al. (2006) Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 440: 1013-1017.
55. Shiau AK, Harris SF, Southworth DR, Agard DA, (2006) Structural Analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell 127: 329-340.
56. Dollins DE, Warren JJ, Immormino RM, Gewirth DT, (2007) Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones. Mol Cell 28: 41-56.
57. Vaughan CK, Gohlke U, Sobott F, Good VM, Ali MM, et al. (2006) Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell 23: 697-707.
58. Richter K, Soroka J, Skalniak L, Leskovar A, Hessling M, et al. (2008) Conserved conformational changes in the ATPase cycle of human Hsp90. J Biol Chem 283: 17757-17765.
59. Zhang W, Hirshberg M, McLaughlin SH, Lazar GA, Grossmann JG, et al. (2004) Biochemical and structural studies of the interaction of Cdc37 with Hsp90. J Mol Biol 340: 891-907.
60. Cunningham CN, Krukenberg KA, Agard DA, (2008) Intra- and intermonomer interactions are required to synergistically facilitate ATP hydrolysis in Hsp90. J Biol Chem 283: 21170-21178.
61. Krukenberg KA, Forster F, Rice LM, Sali A, Agard DA, (2008) Multiple conformations of E. coli Hsp90 in solution: insights into the conformational dynamics of Hsp90. Structure 16: 755-765.
62. Bron P, Giudice E, Rolland JP, Buey RM, Barbier P, et al. (2008) Apo-Hsp90 coexists in two open conformational states in solution. Biol Cell 100: 413-425.
63. Vaughan CK, Piper PW, Pearl LH, Prodromou C, (2009) A common conformationally coupled ATPase mechanism for yeast and human cytoplasm HSP90s. FEBS J 276: 199-209.
64. Southworth DR, Agard DA, (2008) Species-dependent ensembles of conserved conformational states define the Hsp90 chaperone ATPase cycle. Mol Cell 32: 631-640.
65. Krukenberg KA, Southworth DR, Street TO, Agard DA, (2009) pH-dependent conformational changes in bacterial Hsp90 reveal a Grp94-like conformation at pH 6 that is highly active in suppression of citrate synthase aggregation. J Mol Biol 390: 278-291.
66. Phillips JJ, Yao ZP, Zhang W, McLaughlin S, Laue ED, et al. (2007) Conformational dynamics of the molecular chaperone Hsp90 in complexes with a co-chaperone and anticancer drugs. J Mol Biol 372: 1189-1203.
67. Frey S, Leskovar A, Reinstein J, Buchner J, (2007) The ATPase cycle of the endoplasmic chaperone Grp94. J Biol Chem 282: 35612-35620.
68. Mickler M, Hessling M, Ratzke C, Buchner J, Hugel T, (2009) The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis. Nat Struct Mol Biol 16: 281-286.
69. Hessling M, Richter K, Buchner J, (2009) Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90. Nat Struct Mol Biol 16: 287-293.
70. Graf C, Stankiewicz M, Kramer G, Mayer MP, (2009) Spatially and kinetically resolved changes in the conformational dynamics of the Hsp90 chaperone machine. EMBO J 28: 602-613.
71. Tsutsumi S, Mollapour M, Graf C, Lee CT, Scroggins BT, et al. (2009) Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain. Nat Struct Mol Biol 16: 1141-1147.
72. Retzlaff M, Stahl M, Eberl HC, Lagleder S, Beck J, et al. (2009) Hsp90 is regulated by a switch point in the C-terminal domain. EMBO Rep 10: 1147-1153.
73. Ratzke C, Mickler M, Hellenkamp B, Buchner J, Hugel T, (2010) Dynamics of heat shock protein 90 C-terminal dimerization is an important part of its conformational cycle. Proc Natl Acad Sci U S A 107: 16101-16106.
74. Colombo G, Morra G, Meli M, Verkhivker G, (2008) Understanding ligand-based modulation of the Hsp90 molecular chaperone dynamics at atomic resolution. Proc Natl Acad Sci U S A 105: 7976-7981.
75. Morra G, Verkhivker G, Colombo G, (2009) Modeling signal propagation mechanisms and ligand-based conformational dynamics of the Hsp90 molecular chaperone full length dimer. PLoS Comput Biol 5: e1000323.
76. Verkhivker GM, Dixit A, Morra G, Colombo G, (2009) Structural and computational biology of the molecular chaperone Hsp90: from understanding molecular mechanisms to computer-based inhibitor design. Curr Top Med Chem 9: 1369-1385.
77. Hagn F, Lagleder S, Retzlaff M, Rohrberg J, Demmer O, et al. (2011) Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53. Nat Struct Mol Biol 18: 1086-1093.
78. Southworth DR, Agard DA, (2011) Client-loading conformation of the Hsp90 molecular chaperone revealed in the cryo-EM structure of the human Hsp90:Hop complex. Mol Cell 42: 771-781.
79. Street TO, Lavery LA, Agard DA, (2011) Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone. Mol Cell 42: 96-105.
80. Marcu MG, Schulte TW, Neckers LM, (2000) Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins. J Natl Cancer Inst 92: 242-248.
81. Marcu MG, Chadli A, Bouhouche I, Catelli M, Neckers LM, (2000) The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone. J Biol Chem 275: 37181-37186.
82. Garnier C, Lafitte D, Tsvetkov PO, Barbier P, Devin JL, et al. (2002) Binding of ATP to heat shock protein 90: evidence for an ATP-binding site in the C-terminal domain. J Biol Chem 277: 12208-12214.
83. Scheibel T, Weikl T, Buchner J, (1998) Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence. Proc Natl Acad Sci U S A 95: 1495-1499.
84. Johnson BD, Chadli A, Felts SJ, Bouhouche I, Catelli MG, et al. (2000) Hsp90 chaperone activity requires the full-length protein and interaction among its multiple domains. J Biol Chem 275: 32499-32507.
85. Owen BAL, Sullivan WP, Felts SJ, Toft DO, (2002) Regulation of heat shock protein 90 ATPase activity by sequences in the carboxyl terminus. J Biol Chem 277: 7086-7091.
86. Soti C, Racz A, Csermely P, (2002) A Nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket. J Biol Chem 277: 7066-7075.
87. Soti C, Vermes A, Haystead TAJ, Csermely P, (2003) Comparative analysis of the ATP-binding sites of Hsp90 by nucleotide affinity cleavage: a distinct nucleotide specificity of the C-terminal ATP-binding site. Eur J Biochem 270: 2421-2428.
88. Yu XM, Shen G, Neckers L, Blake H, Holzbeierlein J, et al. (2005) Hsp90 inhibitors identified from a library of novobiocin analogues. J Am Chem Soc 127: 12778-12779.
89. Allan RK, Mok D, Ward BK, Ratajczak T, (2006) Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization. J Biol Chem 281: 7161-7171.
90. Le Bras G, Radanyi C, Peyrat JF, Brion JD, Alami M, et al. (2007) New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90. J Med Chem 50: 6189-6200.
91. Burlison JA, Avila C, Vielhauer G, Lubbers DJ, Holzbeierlein J, et al. (2008) Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. J Org Chem 73: 2130-2137.
92. Amolins MW, Blagg BSJ, (2009) Natural product inhibitors of Hsp90: potential leads for drug discovery. Mini Rev Med Chem 9: 140-152.
93. Zhao H, Donnelly AC, Kusuma BR, Brandt GE, Brown D, et al. (2011) Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents. J Med Chem 54: 3839-3853.
94. Morra G, Neves MAC, Plescia CJ, Tsustsumi S, Neckers L, et al. (2010) Dynamics-based discovery of allosteric inhibitors: Selection of new ligands for the C-terminal domain of Hsp90. J Chem Theory Comput 6: 2978-2989.
95. Matts RL, Brandt GEL, Lu Y, Dixit A, Mollapour M, et al. (2011) A systematic protocol for the characterization of Hsp90 modulators. Bioorg Med Chem 19: 684-692.
96. Matts RL, Dixit A, Peterson LB, Sun L, Voruganti S, et al. (2011) Elucidation and assessment of the Hsp90 C-terminal inhibitor binding site. ACS Chem Biol 6: 800-807.
97. Cui Q, Karplus M, (2008) Allostery and cooperativity revisited. Protein Sci 17: 1295-1307.
98. Goodey NM, Benkovic SJ, (2008) Allosteric regulation and catalysis emerge via a common route. Nat Chem Biol 4: 474-482.
99. Tsai CJ, Sol AD, Nussinov R, (2008) Allostery: absence of a change in shape does not imply that allostery is not at play. J Mol Biol 378: 1-11.
100. Tsai CJ, Sol AD, Nussinov R, (2009) Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms. Mol Biosyst 5: 207-216.
101. Sol AD, Sol, Tsai CJ, Ma B, Nussinov R, (2009) The origin of allosteric functional modulation: multiple pre-existing pathways. Structure 17: 1042-1050.
102. Zheng W, Tekpinar M, (2009) Large-scale evaluation of dynamically important residues in proteins predicted by the perturbation analysis of a coarse-grained elastic model. BMC Struct Biol 9: 45.
103. Zheng W, Brooks BR, Thirumalai D, (2009) Allosteric transitions in biological nanomachines are described by robust normal modes of elastic networks. Curr Protein Pept Sci 10: 128-132.
104. Yang L, Song G, Jernigan RL, (2009) Protein elastic network models and the ranges of cooperativity. Proc Natl Acad Sci U S A 106: 12347-12352.
105. Chennubhotla C, Bahar I, (2007) Signal propagation in proteins and relation to equilibrium fluctuations. PLoS Comput Biol 3: 1716-1726.
106. Bahar I, Chennubhotla C, Tobi D, (2007) Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation. Curr Opin Struct Biol 17: 633-640.
107. Yang L-W, Bahar I, (2005) Coupling between catalytic site and collective dynamics: A requirement for mechanochemical activity of enzymes. Structure 13: 893-904.
108. Daily MD, Upadhyaya TJ, Gray JJ, (2008) Contact rearrangements form coupled networks from local motions in allosteric proteins. Proteins 71: 455-466.
109. Daily MD, Gray JJ, (2009) Allosteric communication occurs via networks of tertiary and quaternary motions in proteins. PLoS Comput Biol 5: e1000293.
110. Kidd BA, Baker D, Thomas WE, (2009) Computation of conformational coupling in allosteric proteins. PLoS Comput Biol 5: e1000484.
111. Haliloglu T, Bahar I, Erman B, (1997) Gaussian dynamics of folded proteins. Phys Rev Lett 79: 3090-3093.
112. Bahar I, Atilgan AR, Erman B, (1997) Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. Fold Des 2: 173-181.
113. Atilgan AR, Durell SR, Jernigan RL, Demirel MC, Keskin O, et al. (2001) Anisotropy of fluctuation dynamics of proteins with an elastic network model. Biophys J 80: 505-515.
114. Yang LW, Liu X, Jursa CJ, Holliman M, Rader AJ, et al. (2005) iGNM: a database of protein functional motions based on Gaussian Network Model. Bioinformatics 21: 2978-2987.
115. Zheng W, (2010) Anharmonic normal mode analysis of elastic network model improves the modeling of atomic fluctuations in protein crystal structures. Biophys J 98: 3025-3034.
116. Ma J, (2005) Usefulness and limitations of normal mode analysis in modeling dynamics of biomolecular complexes. Structure 13: 373-380.
117. Bahar I, Rader AJ, (2005) Coarse-grained normal mode analysis in structural biology. Curr Opin Struc Biol 15: 1-7.
118. Bahar I, Lezon TR, Yang LW, Eyal E, (2010) Global dynamics of proteins: bridging between structure and function. Annu Rev Biophys 39: 23-42.
119. Tobi D, Bahar I, (2005) Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. Proc Natl Acad Sci USA 102: 18908-18913.
120. Popovych N, Sun S, Ebright RH, Kalodimos CG, (2006) Dynamically driven protein allostery. Nat Struct Mol Biol 13: 831-838.
121. Hardy JA, Wells JA, (2004) Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 14: 706-715.
122. Maguid S, Fernandez-Alberti S, Ferrelli L, Echave J, (2005) Exploring the common dynamics of homologous proteins. Application to the globin family. Biophys J 89: 3-13.
123. Maguid S, Fernandez-Alberti S, Parisi G, Echave J, (2006) Evolutionary conservation of protein backbone flexibility. J Mol Evol 63: 448-457.
124. Maguid S, Fernandez-Alberti S, Echave J, (2008) Evolutionary conservation of protein vibrational dynamics. Gene 422: 7-13.
125. Keskin O, Jernigan RL, Bahar I, (2000) Proteins with similar architecture exhibit similar large-scale dynamic behavior. Biophys J 78: 2093-2106.
126. Hollup SM, Fuglebakk E, Taylor WR, Reuter N, (2011) Exploring the factors determining the dynamics of different protein folds. Protein Sci 20: 197-209.
127. Skjaerven L, Martinez A, Reuter N, (2011) Principal component and normal mode analysis of proteins; a quantitative comparison using the GroEL subunit. Proteins 79: 232-243.
128. Csermely P, Palotai R, Nussinov R, (2010) Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem Sci 35: 539-546.
129. Ferreiro DU, Hegler JA, Komives EA, Wolynes PG, (2007) Localizing frustration in native proteins and protein assemblies. Proc Natl Acad Sci U S A 104: 19819-19824.
130. Okazaki KI, Takada S, (2008) Dynamic energy landscape view of coupled binding and protein conformational change: induced-fit versus population-shift mechanisms. Proc Natl Acad Sci U S A 105: 11182-11187.
131. Sato S, Fujita N, Tsuruo T, (2000) Modulation of akt kinase activity by binding to hsp90. Proc Natl Acad Sci USA 97: 10832-10837.
132. Mollapour M, Tsutsumi S, Donnelly AC, Beebe K, Tokita MJ, et al. (2010) Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol Cell 37: 333-343.
133. Mollapour M, Tsutsumi S, Truman AW, Xu W, Vaughan CK, et al. (2011) Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Mol Cell 41: 672-681.
134. Tsutsumi S, Mollapour M, Prodromou C, Lee CT, Panaretou B, et al. (2012) Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proc Natl Acad Sci U S A 109: 2937-2942.
135. Millson SH, Truman AW, Wolfram F, King V, Panaretou B, (2004) Investigating the protein-protein interactions of the yeast Hsp90 chaperone system by two-hybrid analysis: potential uses and limitations of this approach Cell Stress Chaperones. 2004 9: 359-368.
136. Gaiser AM, Kretzschmar A, Richter K, (2010) Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors. Biol Chem 285: 40921-40932.
137. Ota A, Zhang J, Ping P, Han J, Wang Y, (2010) Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte. Circ Res 106: 1404-1412.
138. Jiang Y, Bernard D, Yu Y, Xie Y, Zhang T, et al. (2010) Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions. Biol Chem 285: 21023-21036.
139. Richter K, Buchner J, (2011) Closing in on the Hsp90 chaperone-client relationship. Structure 19: 445-446.
140. Lange OF, Lakomek NA, Farès C, Schröder GF, Walter KF, et al. (2008) Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution. Science 320: 1471-1475.
141. Eisenmesser EZ, Millet O, Labeikovsky W, Korzhnev DM, Wolf-Watz M, et al. (2005) Intrinsic dynamics of an enzyme underlies catalysis. Nature 438: 117-121.
142. Tang C, Schwieters CD, Clore GM, (2007) Open-to-closed transition in apo maltose-binding protein observed by paramagnetic NMR. Nature 449: 1078-1082.
143. James LC, Roversi P, Tawfik DS, (2003) Antibody multispecificity mediated by conformational diversity. Science 299: 1362-1367.
144. Piazza F, Sanejouand YH, (2008) Discrete breathers in protein structures. Phys Biol 5: 026001.
145. Luccioli S, Imparato A, Lepri S, Piazza F, Torcini A, (2011) Discrete breathers in a realistic coarse-grained model of proteins. Phys Biol 8: 046008.
146. Halabi N, Rivoire O, Leibler S, Ranganathan R, (2009) Protein sectors: evolutionary units of three-dimensional structure. Cell 138: 774-786.
147. Reynolds KA, McLaughlin RN, Ranganathan R, (2011) Hot spots for allosteric regulation on protein surfaces. Cell 147: 1564-1575.
148. Hieronymus H, Lamb J, Ross KN, Peng XP, Clement C, et al. (2006) Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10: 321-330.
149. Zhang T, Hamza A, Cao X, Wang B, Yu S, et al. (2008) novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells. Mol Cancer Ther 7: 162-170.
150. Zhang T, Li Y, Yu Y, Zou P, Jiang Y, et al. (2009) Characterization of celastrol to inhibit hsp90 and cdc37 interaction. J Biol Chem 284: 35381-35389.
151. Sreeramulu S, Gande SL, Göbel M, Schwalbe H, (2009) Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. Angew Chem Int Ed Engl 48: 5853-5855.
152. Huth JR, Park C, Petros AM, Kunzer AR, Wendt MD, et al. (2007) Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies. Chem Biol Drug Des 70: 1-12.
153. Marti-Renom MA, Stuart A, Fiser A, Sánchez R, Melo A, et al. (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291-325.
154. Fiser A, Do RK, Sali A, (2000) Modeling of loops in protein structures. Protein Sci 9: 1753-1773.
155. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, et al. (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26: 1781-1802.
156. MacKerell AD Jr, Bashford D, Bellott M, Dunbrack RL Jr, Evanseck JD, et al. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102: 3586-3616.
157. MacKerell AD Jr, Banavali N, Foloppe N, (2001) Development and current status of the CHARMM force field for nucleic acids. Biopolymers 56: 257-265.
158. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, et al. (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935.
159. Humphrey W, Dalke A, Schulten K, (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-8, 27-28.
160. Eargle J, Wright D, Luthey-Schulten Z, (2006) Multiple Alignment of protein structures and sequences for VMD. Bioinformatics 22: 504-506.
161. Dixit A, Verkhivker G, (2009) Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations. PLoS Comput Biol 5: e1000487.
162. Dixit A, Verkhivker G, (2011) Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases. PLoS Comput Biol 7: e1002179.
163. Dixit A, Verkhivker G, (2011) The energy landscape analysis of cancer mutations in protein kinases. PLoS One 6: e26071.
164. Amadei A, Linssen AB, Berendsen HJ, (1993) Essential dynamics of proteins. Proteins 17: 412-425.
165. Amadei A, Ceruso MA, Di Nola A, (1999) On the convergence of the conformational coordinates basis set obtained by the essential dynamics analysis of proteins' molecular dynamics simulations. Proteins 36: 419-424.
166. Glykos NM, (2006) Software news and updates. Carma: a molecular dynamics analysis program. J Comput Chem 27: 1765-1768.
167. Yang LW, Eyal E, Bahar I, Kitao A, (2009) Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): insights into functional dynamics. Bioinformatics 25: 606-614.